SUPERPARAMAGNETIC IRON-OXIDE (SPIO) AS AN ORAL CONTRAST AGENT IN GASTROINTESTINAL (GI) MAGNETIC-RESONANCE-IMAGING (MRI) - COMPARISON WITH STATE-OF-THE-ART COMPUTED-TOMOGRAPHY (CT)
Wk. Johnson et al., SUPERPARAMAGNETIC IRON-OXIDE (SPIO) AS AN ORAL CONTRAST AGENT IN GASTROINTESTINAL (GI) MAGNETIC-RESONANCE-IMAGING (MRI) - COMPARISON WITH STATE-OF-THE-ART COMPUTED-TOMOGRAPHY (CT), Magnetic resonance imaging, 14(1), 1996, pp. 43-49
This study was conducted to compare the sensitivity and specificity of
abdominal magnetic resonance imaging using oral superparamagnetic iro
n oxide with oral contrast-enhanced computed tomography in the detecti
on of GI pathology. Overall sensitivity was calculated to be 83% for O
ECT compared to 67% by SPIO MRI. Specificity for OECT was 68% compared
to 89% for SPIO MRI, The results from imaging with superparamagnetic
iron oxide and imaging with oral contrast-enhanced computed tomography
were in agreement in 14 subjects who had normal gastrointestinal trac
ts, In the remaining 16 patients, eight pathologic entities were detec
ted by both modalities whereas 15 abnormalities were seen by only one
modality. Superparamagnetic iron oxide magnetic resonance imaging was
helpful in discriminating normal bowel from solid lesions and in detec
ting subtle gastrointestinal tract mass effect. In 30 consecutively st
udied patients suspected of having GI pathology, OECT was more sensiti
ve than SPIO MRI in detecting abdominal pathology, Conversely, SPIO MR
I was more specific than OECT.